Cargando…

Characteristics of Renal Cell Carcinoma Harboring TPM3-ALK Fusion

The World Health Organization 2016 edition assigned anaplastic lymphoma kinase (ALK) rearrangement-associated renal cell carcinoma (ALK-RCC) as an emerging renal tumor entity. Identifying ALK-RCC is important because ALK inhibitors have been shown to be effective in treatment. Here, we report the ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Woo, Chang Gok, Yun, Seok Jung, Son, Seung-Myoung, Lim, Young Hyun, Lee, Ok-Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044692/ https://www.ncbi.nlm.nih.gov/pubmed/32102128 http://dx.doi.org/10.3349/ymj.2020.61.3.262

Ejemplares similares

The effects of crizotinib in a transgenic Drosophila model expressing the human TPM4-ALK fusion gene or TPM4
por: Kim, Yoo Jin, et al.
Publicado: (2019)

Inflammatory myofibroblastic tumor of the urinary bladder with FN1‑ALK gene fusion: A case report
por: Son, Seung-Myoung, et al.
Publicado: (2023)

ALK-TPM3 rearrangement in adult renal cell carcinoma: a case report and literature review
por: Yang, Jing, et al.
Publicado: (2019)

Response to crizotinib in a patient with metastatic lung spindle cell carcinoma harboring TPM3-ROS1 fusion
por: Cai, Cun-Liang, et al.
Publicado: (2019)

Uterine mesenchymal tumors harboring ALK fusions and response to ALK-targeted therapy
por: Kyi, Chrisann, et al.
Publicado: (2021)

Dual drive coexistence of EML4‐ALK and TPM3‐ROS1 fusion in advanced lung adenocarcinoma
por: Zhu, You‐cai, et al.
Publicado: (2017)

Primary retroperitoneal mucinous cystic neoplasm of borderline malignancy with KRAS and GNAS co-mutation: a case report
por: Son, Seung-Myoung, et al.
Publicado: (2023)

Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with the variant RNF213-, ATIC- and TPM3-ALK fusions is characterized by copy number gain of the rearranged ALK gene
por: van der Krogt, Jo-Anne, et al.
Publicado: (2017)

Implementing TPM
por: Ginder, Andrew, et al.
Publicado: (2020)

Crizotinib in Sarcomatous Malignancies Harboring ALK Fusion With a Definitive Partner(s): Response and Efficacy
por: Wu, Jinchun, et al.
Publicado: (2021)

Clinicopathological characteristics of costal hemangiomas: a case report and literature review
por: Woo, Chang Gok, et al.
Publicado: (2018)

A case of lung adenocarcinoma harboring EGFR mutation and EML4-ALK fusion gene
por: Tanaka, Hisashi, et al.
Publicado: (2012)

Genomic Features of Solid Tumor Patients Harboring ALK/ROS1/NTRK Gene Fusions
por: Dai, Yinghuan, et al.
Publicado: (2022)

Genomic Profiling Reveals Synchronous Bilateral Lung Adenocarcinomas With Distinct Driver Alterations of EML4-ALK or TPM3-ROS1 Fusion: A Case Report
por: Tan, Benxu, et al.
Publicado: (2019)

The expression and clinical significance of TPM4 in hepatocellular carcinoma
por: Li, Linjing, et al.
Publicado: (2021)

The prognostic value of TPM1–4 in hepatocellular carcinoma
por: Tian, Zhihui, et al.
Publicado: (2021)

A case of large-cell neuroendocrine carcinoma harboring rare ALK fusion with initial response to the ALK inhibitor crizotinib and acquired F1174L mutation after resistance
por: Wang, Ye, et al.
Publicado: (2019)

Afatinib Overcomes Pemetrexed-Acquired Resistance in Non-Small Cell Lung Cancer Cells Harboring an EML4-ALK Rearrangement
por: Kwon, Ji-Hyun, et al.
Publicado: (2019)

Inflammatory Myofibroblastic Tumor of the Upper Airways Harboring a New TRAF3-ALK Fusion Transcript
por: Di Ruscio, Valentina, et al.
Publicado: (2021)

Corresponding anaplastic lymphoma kinase–tropomyosin 3 (ALK-TPM3) fusion in a patient with a primary cutaneous anaplastic large-cell lymphoma and a Spitz nevus
por: Melchers, Rutger C., et al.
Publicado: (2019)

Loss of crossbridge inhibition drives pathological cardiac hypertrophy in patients harboring the TPM1 E192K mutation
por: Sewanan, Lorenzo R., et al.
Publicado: (2021)

Ticket Processing Management (TPM)
por: Mario David
Publicado: (2006)

Clinicopathological Characteristics of Patients with Non-Small-Cell Lung Cancer Who Harbor EML4-ALK Fusion Gene: A Meta-Analysis
por: Zhao, Fengzhi, et al.
Publicado: (2015)

Tropomyosin is essential in yeast, yet the TPM1 and TPM2 products perform distinct functions
Publicado: (1995)

Thin filament dysfunctions caused by mutations in tropomyosin Tpm3.12 and Tpm1.1
por: Moraczewska, Joanna
Publicado: (2019)

Structural and Functional Peculiarities of Cytoplasmic Tropomyosin Isoforms, the Products of TPM1 and TPM4 Genes
por: Marchenko, Marina, et al.
Publicado: (2021)

Chromoplectic TPM3–ALK rearrangement in a patient with inflammatory myofibroblastic tumor who responded to ceritinib after progression on crizotinib
por: Mansfield, A. S., et al.
Publicado: (2016)

CMTR1-ALK: an ALK fusion in a patient with no response to ALK inhibitor crizotinib
por: Du, Xue, et al.
Publicado: (2018)

Infantile fibrosarcoma with TPM3-NTRK1 fusion in a boy with Bloom syndrome
por: Huson, Sue M., et al.
Publicado: (2020)

TPM3 and TPM4 gene products segregate to the postsynaptic region of central nervous system synapses
por: Guven, Kim, et al.
Publicado: (2011)

eTPM: A Trusted Cloud Platform Enclave TPM Scheme Based on Intel SGX Technology
por: Sun, Haonan, et al.
Publicado: (2018)

ORMDL3 expression in ASM regulates hypertrophy, hyperplasia via TPM1 and TPM4, and contractility
por: Pham, Alexa K., et al.
Publicado: (2021)

Carcinosarcoma of the parotid gland with abdominal metastasis: a case report and review of literature
por: Woo, Chang Gok, et al.
Publicado: (2018)

Schwannoma originating from the common iliac artery: a case report
por: Son, Seung-Myoung, et al.
Publicado: (2019)

Response to ALK‐TKIs in a lung adenocarcinoma patient harboring dual DCTN1‐ALK and ALK‐CLIP4 rearrangements
por: Gao, Fangfang, et al.
Publicado: (2022)

Management of Oligoprogression in Patients with Metastatic NSCLC Harboring ALK Rearrangements
por: Pisano, Chiara, et al.
Publicado: (2022)

Clinicopathological features of younger (aged ≤ 50 years) lung adenocarcinoma patients harboring the EML4‐ALK fusion gene
por: Kometani, Takuro, et al.
Publicado: (2018)

Large Cell Neuroendocrine Carcinoma Harboring an Anaplastic Lymphoma Kinase (ALK) Rearrangement with Response to Alectinib
por: Hayashi, Nobuyoshi, et al.
Publicado: (2017)

Responses to ALK Inhibitor Treatments in a Patient with Non-Small Cell Lung Cancer Harboring a Novel HPCAL1-ALK Fusion Variant: A Case Report
por: Wang, Ruixiao, et al.
Publicado: (2020)

Expression of TPM1κ, a Novel Sarcomeric Isoform of the TPM1 Gene, in Mouse Heart and Skeletal Muscle
por: Dube, Syamalima, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_l70nvvvkkf7tveq1hnho9h6l75